臨床眼科63巻1号

2009年01月発行

連載 今月の話題

一酸化窒素と網膜疾患

著者： 米今敬一¹

所属機関： ¹名古屋大学大学院医学系研究科眼科学・感覚器障害制御学教室

ページ範囲：P.9 - P.14

　一酸化窒素（NO）には実に多様な生理活性作用があり，その不足や過剰産生は全身のさまざまな疾患に関与している。本稿においては，代表的な網膜硝子体疾患である糖尿病網膜症，加齢黄斑変性，未熟児網膜症および網膜色素変性症におけるNOの果たしている役割に焦点を絞り，臨床医がその病態生理を考察する際の手助けとなるように最新の知見を疾患別に紹介する。

参考文献

1）藤崎美奈子・一守康史・中澤博江：NOの代謝と測定法．大柳善彦（編）：NOラジカルの医学．14-28，羊土社，東京，1996

2）平田結喜緒：NOSの構造と機能．大柳善彦（編）：NOラジカルの医学．29-41，羊土社，東京，1996

3）Toda N, Nakanishi-Toda M：Nitric oxide：ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res　26：205-238, 2007

4）Doganay S, Evereklioglu C, Er H et al：Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye　16：163-170, 2002

5）Ozden S, Tatlipinar S, Biçer N et al：Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. Can J Ophthalmol　38：393-396, 2003

6）Cicik E, Tekin H, Akar S et al：Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Res　35：251-255, 2003

7）Hernández C, Lecube A, Segura RM et al：Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med　19：655-660, 2002

8）Abu El-Asrar AM, Van Aelst I, Al-Mansouri S et al：Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol　132：551-556, 2001

9）Schaefer S, Kajimura M, Tsuyama S et al：Aberrant utilization of nitric oxide and regulation of soluble guanylate cyclase in rat diabetic retinopathy. Antioxid Redox Signal　5：457-465, 2003

10）Sennlaub F, Courtois Y, Goureau O：Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest　107：717-725, 2001

11）Sennlaub F, Courtois Y, Goureau O：Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci　22：3987-3993, 2002

12）Du XL, Edelstein D, Dimmeler S et al：Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest　108：1341-1348, 2001

13）El-Remessy AB, Abou-Mohamed G, Caldwell RW et al：High glucose-induced tyrosine nitration in endothelial cells：role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci　44：3135-3143, 2003

14）Evereklioglu C, Er H, Doganay S et al：Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol　106：129-136, 2003

15）Totan Y, Cekiç O, Borazan M et al：Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br J Ophthalmol　85：1426-1428, 2008

16）Tsai DC, Charng MJ, Lee FL et al：Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica　220：246-251, 2006

17）Ando A, Yang A, Nambu H et al：Blockade of nitric-oxide synthase reduces choroidal neovascularization. Mol Pharmacol　62：539-544, 2002

18）Ando A, Yang A, Mori K et al：Nitric oxide is proangiogenic in the retina and choroid. J Cell Physiol　191：116-124, 2002

19）Hattenbach LO, Falk B, Nürnberger F et al：Detection of inducible nitric oxide synthase and vascular endothelial growth factor in choroidal neovascular membranes. Ophthalmologica　216：209-214, 2002

20）She H, Nakazawa T, Matsubara A et al：Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci　48：2268-2277, 2007

21）Beauchamp MH, Sennlaub F, Speranza G et al：Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. Free Radic Biol Med　37：1885-1894, 2004

22）Alon T, Hemo I, Itin A et al：Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med　1：1024-1028, 1995

23）Brooks SE, Gu X, Samuel S et al：Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci　42：222-228, 2001

24）Gu X, El-Remessy AB, Brooks SE et al：Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol　285：C546-C554, 2003

25）Kermorvant-Duchemin E, Sennlaub F, Sirinyan M et al：Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat Med　11：1339-1345, 2005

26）Smith LE, Connor KM：A radically twisted lipid regulates vascular death. Nat Med　11：1275-1276, 2005

27）Káldi I, Dittmar M, Pierce P et al：L-NAME protects against acute light damage in albino rats, but not against retinal degeneration in P23H and S334ter transgenic rats. Exp Eye Res　76：453-461, 2003

28）Komeima K, Usui S, Shen J et al：Blockade of neuronal nitric oxide synthase reduces cone cell death in a model of retinitis pigmentosa. Free Radic Biol Med　45：905-912, 2008

29）Hughes EH, Schlichtenbrede FC, Murphy CC et al：Generation of activated sialoadhesin-positive microglia during retinal degeneration. Invest Ophthalmol Vis Sci　44：2229-2234, 2003